230 related articles for article (PubMed ID: 32497049)
1. The cost of a school based mass treatment of schistosomiasis in Ugu District, KwaZulu Natal, South Africa in 2012.
Maphumulo A; Mahomed O; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
PLoS One; 2020; 15(6):e0232867. PubMed ID: 32497049
[TBL] [Abstract][Full Text] [Related]
2. The cost of large-scale school health programmes which deliver anthelmintics to children in Ghana and Tanzania. The Partnership for Child Development.
Acta Trop; 1999 Jul; 73(2):183-204. PubMed ID: 10465058
[TBL] [Abstract][Full Text] [Related]
3. Controlling schistosomiasis: the cost-effectiveness of alternative delivery strategies.
Guyatt H; Evans D; Lengeler C; Tanner M
Health Policy Plan; 1994 Dec; 9(4):385-95. PubMed ID: 10139471
[TBL] [Abstract][Full Text] [Related]
4. Cost of school-based drug treatment in Tanzania. The Partnership for Child Development.
Health Policy Plan; 1998 Dec; 13(4):384-96. PubMed ID: 10346030
[TBL] [Abstract][Full Text] [Related]
5. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model.
Stothard JR
Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):325-32. PubMed ID: 19171359
[TBL] [Abstract][Full Text] [Related]
6. Cost of interventions to control schistosomiasis: A systematic review of the literature.
Salari P; Fürst T; Knopp S; Utzinger J; Tediosi F
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008098. PubMed ID: 32226008
[TBL] [Abstract][Full Text] [Related]
7. The presumptive treatment of all school-aged children is the least costly strategy for schistosomiasis control in Plateau and Nasarawa states, Nigeria.
Gutman J; Richards FO; Eigege A; Umaru J; Alphonsus K; Miri ES
Ann Trop Med Parasitol; 2009 Sep; 103(6):501-11. PubMed ID: 19695155
[TBL] [Abstract][Full Text] [Related]
8. Treating schistosomiasis among South African high school pupils in an endemic area, a qualitative study.
Lothe A; Zulu N; Øyhus AO; Kjetland EF; Taylor M
BMC Infect Dis; 2018 May; 18(1):239. PubMed ID: 29801483
[TBL] [Abstract][Full Text] [Related]
9. Mapping Schistosoma haematobium for Novel Interventions against Female Genital Schistosomiasis and Associated HIV Risk in KwaZulu-Natal, South Africa.
Livingston M; Pillay P; Zulu SG; Sandvik L; Kvalsvig JD; Gagai S; Galappaththi-Arachchige HN; Kleppa E; Ndhlovu P; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
Am J Trop Med Hyg; 2021 May; 104(6):2055-2064. PubMed ID: 33939629
[TBL] [Abstract][Full Text] [Related]
10. Can direct smear results that are routinely collected at health centre level be used for monitoring the impact of mass drug administration with praziquantel on schistosomiasis in Burundi? A preliminary assessment.
Bizimana P; Polman K; Ortu G; Krit M; Nsabiyumva F; Nkeshimana A; Bijabuka U; Nibakire M; Van Geertruyden JP
Parasit Vectors; 2020 Apr; 13(1):206. PubMed ID: 32317007
[TBL] [Abstract][Full Text] [Related]
11. A prospective risk assessment of the implementation of a schistosomiasis preventive mass drug administration for children aged five years and below in the uMkhanyakude district of KwaZulu-Natal.
Ncube MV; Chimbari MJ
BMC Health Serv Res; 2019 Oct; 19(1):685. PubMed ID: 31590663
[TBL] [Abstract][Full Text] [Related]
12. Praziquantel-related visual disorders among recipients in mass drug administration campaigns in schistosomiasis endemic settings: Systematic review and meta-analysis protocol.
Danso-Appiah A; Owiredu D; Akuffo KO
PLoS One; 2024; 19(5):e0300384. PubMed ID: 38758736
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC
BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549
[TBL] [Abstract][Full Text] [Related]
14. Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting.
Binder S; Campbell CH; Castleman JD; Kittur N; Kinung'hi SM; Olsen A; Magnussen P; Karanja DMS; Mwinzi PNM; Montgomery SP; Secor WE; Phillips AE; Dhanani N; Gazzinelli-Guimaraes PH; Clements MN; N'Goran EK; Meite A; Utzinger J; Hamidou AA; Garba A; Fleming FM; Whalen CC; King CH; Colley DG
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):105-113. PubMed ID: 32400352
[TBL] [Abstract][Full Text] [Related]
15. Evaluating survey designs for targeting preventive chemotherapy against Schistosoma haematobium and Schistosoma mansoni across sub-Saharan Africa: a geostatistical analysis and modelling study.
Fornace KM; Fronterrè C; Fleming FM; Simpson H; Zoure H; Rebollo M; Mwinzi P; Vounatsou P; Pullan RL
Parasit Vectors; 2020 Nov; 13(1):555. PubMed ID: 33203463
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations.
Turner HC; Truscott JE; Bettis AA; Farrell SH; Deol AK; Whitton JM; Fleming FM; Anderson RM
Parasit Vectors; 2017 Apr; 10(1):213. PubMed ID: 28454578
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and intensity of neglected tropical diseases (schistosomiasis and soil-transmitted helminths) amongst rural female pupils in Ugu district, KwaZulu-Natal, South Africa.
Zulu SG; Kjetland EF; Gundersen SG; Taylor M
S Afr J Infect Dis; 2020; 35(1):123. PubMed ID: 34485471
[TBL] [Abstract][Full Text] [Related]
18. Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.
Ndeffo Mbah ML; Poolman EM; Atkins KE; Orenstein EW; Meyers LA; Townsend JP; Galvani AP
PLoS Negl Trop Dis; 2013; 7(8):e2346. PubMed ID: 23936578
[TBL] [Abstract][Full Text] [Related]
19. An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel.
Sousa-Figueiredo JC; Day M; Betson M; Kabatereine NB; Stothard JR
Trans R Soc Trop Med Hyg; 2010 Nov; 104(11):740-2. PubMed ID: 20832093
[TBL] [Abstract][Full Text] [Related]
20. Willingness to pay for praziquantel treatment in a hyperendemic community of Ogun State, Nigeria.
Adeneye AK; Mafe MA; Appelt B; Idowu ET; Akande DO
Res Social Adm Pharm; 2006 Mar; 2(1):83-95. PubMed ID: 17138502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
